Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03108131
Title Cobimetinib and Atezolizumab in Advanced Rare Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

small intestine adenocarcinoma

appendix adenocarcinoma

skin squamous cell carcinoma

Therapies

Atezolizumab + Cobimetinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.